Alaunos Therapeutics Inc (TCRT) — Cash Flow Reinvestment Rate
Latest as of September 2015:
0.00x
Alaunos Therapeutics Inc (TCRT) has a Cash Flow Reinvestment Rate of 0.00x as of September 2015, reinvesting $3.00K (capex $3.00K ) from operating cash flow of $45.20 Million. Explore TCRT capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$3.00K
Capex + Investments
Operating Cash Flow
$45.20 Million
USD
Capital Expenditures
$3.00K
USD
Annual Cash Flow Reinvestment Rate for Alaunos Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Alaunos Therapeutics Inc. For live market cap and broader valuation context, see Alaunos Therapeutics Inc (TCRT) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow